NEW YORK (GenomeWeb News) - Cancer diagnostics developer Almac Diagnostics said today it is undertaking a collaborative study with Oxford University that will seek to create a gene signature to predict the recurrence of ductal carcinoma in situ, a type of breast cancer.
 
The study will use the company’s Breast Cancer DSA microarray to help generate a gene expression signature that would be used to identify patients who are likely to experience a recurrence of DCIS.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Stat News reports that the head of IBM Watson Health is leaving her post.